Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1989 1
2009 1
2010 1
2011 1
2012 1
2013 3
2014 2
2015 4
2016 7
2017 7
2018 3
2020 3
2021 4
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Complex interactions of cellular players in chronic Graft-versus-Host Disease.
Gail LM, Schell KJ, Łacina P, Strobl J, Bolton SJ, Steinbakk Ulriksen E, Bogunia-Kubik K, Greinix H, Crossland RE, Inngjerdingen M, Stary G. Gail LM, et al. Among authors: crossland re. Front Immunol. 2023 Jun 26;14:1199422. doi: 10.3389/fimmu.2023.1199422. eCollection 2023. Front Immunol. 2023. PMID: 37435079 Free PMC article. Review.
Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.
Crossland RE, Perutelli F, Bogunia-Kubik K, Mooney N, Milutin Gašperov N, Pučić-Baković M, Greinix H, Weber D, Holler E, Pulanić D, Wolff D, Dickinson AM, Inngjerdingen M, Grce M. Crossland RE, et al. Front Immunol. 2020 Dec 23;11:602547. doi: 10.3389/fimmu.2020.602547. eCollection 2020. Front Immunol. 2020. PMID: 33424849 Free PMC article. Review.
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.
Bojanic I, Worel N, Pacini CP, Stary G, Piekarska A, Flinn AM, Schell KJ, Gennery AR, Knobler R, Lacerda JF, Greinix HT, Pulanic D, Crossland RE. Bojanic I, et al. Among authors: crossland re. Front Immunol. 2023 Feb 17;14:1086006. doi: 10.3389/fimmu.2023.1086006. eCollection 2023. Front Immunol. 2023. PMID: 36875063 Free PMC article. Review.
B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Juric MK, Shevtsov M, Mozes P, Ogonek J, Crossland RE, Dickinson AM, Greinix HT, Holler E, Weissinger EM, Multhoff G. Juric MK, et al. Among authors: crossland re. Front Immunol. 2017 Jan 16;7:660. doi: 10.3389/fimmu.2016.00660. eCollection 2016. Front Immunol. 2017. PMID: 28138325 Free PMC article. Review.
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma.
Newman AM, Zaka M, Zhou P, Blain AE, Erhorn A, Barnard A, Crossland RE, Wilkinson S, Enshaei A, De Zordi J, Harding F, Taj M, Wood KM, Televantou D, Turner SD, Burke GAA, Harrison CJ, Bomken S, Bacon CM, Rand V. Newman AM, et al. Among authors: crossland re. Leukemia. 2022 Mar;36(3):781-789. doi: 10.1038/s41375-021-01444-6. Epub 2021 Oct 21. Leukemia. 2022. PMID: 34675373 Free PMC article.
IT/QA and Regulatory Aspects of Digital Pathology: Results of the 8th ESTP International Workshop.
Boisclair J, Bawa B, Barale-Thomas E, Bertrand L, Carter J, Crossland R, Dorn C, Forest T, Grote S, Gilis A, Hildebrand D, Knight B, Laurent S, Marxfeld HA, Østergaard SJ, Roguet T, Schlueter T, Schumacher V, Spehar R, Varady W, Zeugin C. Boisclair J, et al. Among authors: crossland r. Toxicol Pathol. 2022 Aug;50(6):793-807. doi: 10.1177/01926233221113275. Epub 2022 Aug 11. Toxicol Pathol. 2022. PMID: 35950710
42 results